| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 防粘连及止血产品(元) | 229,625,091.12 | 110,393,914.39 | 145,641,599.89 | 69,166,023.65 |
| 骨科产品(元) | 427,703,131.56 | 226,807,784.77 | 456,531,135.32 | 232,805,608.37 |
| 眼科产品(元) | 724,734,512.32 | 367,541,014.84 | 857,649,718.65 | 451,567,565.92 |
| 整形美容与创面护理产品(元) | 1,040,077,586.97 | 575,449,757.58 | 1,195,114,823.11 | 634,499,020.40 |
| 其他产品(元) | 36,680,228.39 | 24,210,299.50 | 38,001,926.85 | 16,405,494.48 |
| 营业成本(元) | ||||
| 防粘连及止血产品(元) | 60,682,256.00 | 32,371,328.63 | 49,908,078.31 | 23,402,030.69 |
| 骨科产品(元) | 96,388,238.53 | 51,330,783.83 | 96,642,473.07 | 46,209,208.68 |
| 眼科产品(元) | 322,335,331.47 | 163,054,252.94 | 368,697,729.72 | 195,052,247.32 |
| 整形美容与创面护理产品(元) | 232,969,248.39 | 130,582,328.80 | 269,295,906.32 | 141,203,800.76 |
| 其他产品(元) | 22,353,964.10 | 11,794,987.44 | 26,334,606.62 | 8,244,181.38 |
| 毛利(元) | ||||
| 防粘连及止血产品(元) | 168,942,835.12 | 78,022,585.76 | 95,733,521.58 | 45,763,992.96 |
| 骨科产品(元) | 331,314,893.03 | 175,477,000.94 | 359,888,662.25 | 186,596,399.69 |
| 眼科产品(元) | 402,399,180.85 | 204,486,761.90 | 488,951,988.93 | 256,515,318.60 |
| 整形美容与创面护理产品(元) | 807,108,338.58 | 444,867,428.78 | 925,818,916.79 | 493,295,219.64 |
| 其他产品(元) | 14,326,264.29 | 12,415,312.06 | 11,667,320.23 | 8,161,313.10 |
| 毛利率(%) | ||||
| 防粘连及止血产品(%) | 73.57 | 70.68 | 65.73 | 66.17 |
| 骨科产品(%) | 77.46 | 77.37 | 78.83 | 80.15 |
| 眼科产品(%) | 55.52 | 55.64 | 57.01 | 56.81 |
| 整形美容与创面护理产品(%) | 77.60 | 77.31 | 77.47 | 77.75 |
| 其他产品(%) | 39.06 | 51.28 | 30.70 | 49.75 |
| 收入构成(%) | ||||
| 防粘连及止血产品(%) | 9.34 | 8.46 | 5.41 | 4.92 |
| 骨科产品(%) | 17.39 | 17.39 | 16.95 | 16.58 |
| 眼科产品(%) | 29.47 | 28.18 | 31.85 | 32.15 |
| 整形美容与创面护理产品(%) | 42.30 | 44.12 | 44.38 | 45.18 |
| 其他产品(%) | 1.49 | 1.86 | 1.41 | 1.17 |
| 毛利构成(%) | ||||
| 防粘连及止血产品(%) | 9.80 | 8.52 | 5.09 | 4.62 |
| 骨科产品(%) | 19.22 | 19.17 | 19.12 | 18.84 |
| 眼科产品(%) | 23.34 | 22.34 | 25.98 | 25.90 |
| 整形美容与创面护理产品(%) | 46.81 | 48.61 | 49.19 | 49.81 |
| 其他产品(%) | 0.83 | 1.36 | 0.62 | 0.82 |